These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34708234)

  • 41. CD36 promotes de novo lipogenesis in hepatocytes through INSIG2-dependent SREBP1 processing.
    Zeng H; Qin H; Liao M; Zheng E; Luo X; Xiao A; Li Y; Chen L; Wei L; Zhao L; Ruan XZ; Yang P; Chen Y
    Mol Metab; 2022 Mar; 57():101428. PubMed ID: 34974159
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Osteoprotegerin Promotes Liver Steatosis by Targeting the ERK-PPAR-γ-CD36 Pathway.
    Zhang C; Luo X; Chen J; Zhou B; Yang M; Liu R; Liu D; Gu HF; Zhu Z; Zheng H; Li L; Yang G
    Diabetes; 2019 Oct; 68(10):1902-1914. PubMed ID: 31292134
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chemically synthesized osteocalcin alleviates NAFLD via the AMPK-FOXO1/BCL6-CD36 pathway.
    Zhang M; Dong K; Du Q; Xu J; Bai X; Chen L; Yang J
    J Transl Med; 2024 Aug; 22(1):782. PubMed ID: 39175012
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sweroside ameliorates NAFLD in high-fat diet induced obese mice through the regulation of lipid metabolism and inflammatory response.
    Yang Q; Shu F; Gong J; Ding P; Cheng R; Li J; Tong R; Ding L; Sun H; Huang W; Wang Z; Yang L
    J Ethnopharmacol; 2020 Jun; 255():112556. PubMed ID: 31926984
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased placental fatty acid transporter 6 and binding protein 3 expression and fetal liver lipid accumulation in a mouse model of obesity in pregnancy.
    Díaz P; Harris J; Rosario FJ; Powell TL; Jansson T
    Am J Physiol Regul Integr Comp Physiol; 2015 Dec; 309(12):R1569-77. PubMed ID: 26491104
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Abrogation of GH action in Kupffer cells results in increased hepatic CD36 expression and exaggerated nonalcoholic fatty liver disease.
    Zhang S; Lu C; Das AK; Pasupulati AK; Menon RK
    Growth Horm IGF Res; 2018; 42-43():74-79. PubMed ID: 30321786
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MicroRNA-205 ameliorates lipid accumulation in non-alcoholic fatty liver disease through targeting NEU1.
    Hu Y; Ye H; Shi LX
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):10072-10082. PubMed ID: 31799678
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of fibroblast growth factor 21 in the early stage of NASH induced by methionine- and choline-deficient diet.
    Tanaka N; Takahashi S; Zhang Y; Krausz KW; Smith PB; Patterson AD; Gonzalez FJ
    Biochim Biophys Acta; 2015 Jul; 1852(7):1242-52. PubMed ID: 25736301
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SIRT1 upregulation protects against liver injury induced by a HFD through inhibiting CD36 and the NF‑κB pathway in mouse kupffer cells.
    Niu B; He K; Li P; Gong J; Zhu X; Ye S; Ou Z; Ren G
    Mol Med Rep; 2018 Aug; 18(2):1609-1615. PubMed ID: 29845302
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hypoxia-inducible factor 2α drives hepatosteatosis through the fatty acid translocase CD36.
    Rey E; Meléndez-Rodríguez F; Marañón P; Gil-Valle M; Carrasco AG; Torres-Capelli M; Chávez S; Del Pozo-Maroto E; Rodríguez de Cía J; Aragonés J; García-Monzón C; González-Rodríguez Á
    Liver Int; 2020 Oct; 40(10):2553-2567. PubMed ID: 32432822
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Emodin palliates high-fat diet-induced nonalcoholic fatty liver disease in mice via activating the farnesoid X receptor pathway.
    Shen C; Pan Z; Wu S; Zheng M; Zhong C; Xin X; Lan S; Zhu Z; Liu M; Wu H; Huang Q; Zhang J; Liu Z; Si Y; Tu H; Deng Z; Yu Y; Liu H; Zhong Y; Guo J; Cai J; Xian S
    J Ethnopharmacol; 2021 Oct; 279():114340. PubMed ID: 34171397
    [TBL] [Abstract][Full Text] [Related]  

  • 52.
    Lebeau PF; Byun JH; Platko K; Al-Hashimi AA; Lhoták Š; MacDonald ME; Mejia-Benitez A; Prat A; Igdoura SA; Trigatti B; Maclean KN; Seidah NG; Austin RC
    JHEP Rep; 2019 Dec; 1(6):418-429. PubMed ID: 32039393
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ezetimibe prevents the development of non‑alcoholic fatty liver disease induced by high‑fat diet in C57BL/6J mice.
    Wang X; Ren Q; Wu T; Guo Y; Liang Y; Liu S
    Mol Med Rep; 2014 Dec; 10(6):2917-23. PubMed ID: 25310357
    [TBL] [Abstract][Full Text] [Related]  

  • 54. KLF10 promotes nonalcoholic steatohepatitis progression through transcriptional activation of zDHHC7.
    Yang S; Jia L; Xiang J; Yang G; Qiu S; Kang L; Zheng P; Liang Z; Lu Y
    EMBO Rep; 2022 Jun; 23(6):e54229. PubMed ID: 35492028
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatocyte CD36 protects mice from NASH diet-induced liver injury and fibrosis via blocking N1ICD production.
    Li Y; Zhang L; Jiao J; Ding Q; Li Y; Zhao Z; Luo J; Chen Y; Ruan X; Zhao L
    Biochim Biophys Acta Mol Basis Dis; 2023 Oct; 1869(7):166800. PubMed ID: 37423141
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of hepatocyte nuclear factor 1b induces hepatic steatosis through DPP4/NOX1-mediated regulation of superoxide.
    Long Z; Cao M; Su S; Wu G; Meng F; Wu H; Liu J; Yu W; Atabai K; Wang X
    Free Radic Biol Med; 2017 Dec; 113():71-83. PubMed ID: 28942246
    [TBL] [Abstract][Full Text] [Related]  

  • 57. FoxO3 regulates hepatic triglyceride metabolism via modulation of the expression of sterol regulatory-element binding protein 1c.
    Wang L; Zhu X; Sun X; Yang X; Chang X; Xia M; Lu Y; Xia P; Yan H; Bian H; Gao X
    Lipids Health Dis; 2019 Nov; 18(1):197. PubMed ID: 31729980
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MicroRNA-27a regulates hepatic lipid metabolism and alleviates NAFLD via repressing FAS and SCD1.
    Zhang M; Sun W; Zhou M; Tang Y
    Sci Rep; 2017 Nov; 7(1):14493. PubMed ID: 29101357
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Systemic loss of CD36 aggravates NAFLD-related HCC through MEK1/2-ERK1/2 signaling pathway.
    Zheng E; Chen Q; Xiao A; Luo X; Lu Q; Tian C; Liu H; Zhao J; Wei L; Yang P; Chen Y
    Biochem Biophys Res Commun; 2024 May; 707():149781. PubMed ID: 38492244
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cathelicidin suppresses lipid accumulation and hepatic steatosis by inhibition of the CD36 receptor.
    Hoang-Yen Tran D; Hoang-Ngoc Tran D; Mattai SA; Sallam T; Ortiz C; Lee EC; Robbins L; Ho S; Lee JE; Fisseha E; Shieh C; Sideri A; Shih DQ; Fleshner P; McGovern DP; Vu M; Hing TC; Bakirtzi K; Cheng M; Su B; Law I; Karagiannides I; Targan SR; Gallo RL; Li Z; Koon HW
    Int J Obes (Lond); 2016 Sep; 40(9):1424-34. PubMed ID: 27163748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.